The changes in clinical laboratory parameters were either restored to their respective baselines or showed a trend toward recovery 2 weeks after discontinuing administration of investigational product (Table S2 ). 4.
← all excerpts
Efficacy and safety of bexagliflozin compared with dapagliflozin as an adjunct to metformin in Chinese patients with type 2 diabetes mellitus: A 24-week, randomized, double-blind, active-controlled, phase 3 trial.
1
—
—